Transcription Factor Profiling Shows New Ways Towards New Treatment Options of Cutaneous T cell lymphomas

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|4|1|24-30

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.4, Iss.1, 2007-06, pp. : 24-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Targets of Therapy in T-Cell Lymphomas

By  

Current Drug Targets, Vol. 11, Iss. 4, 2010-04 ,pp. : 482-493

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs in cutaneous T-cell lymphomas

By Dummer Reinhard  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 381-392

Informa Healthcare

Access to resources Recommend Favorite

Novel treatment avenues for peripheral T-cell lymphomas

By Hopfinger Georg   Griessl Robert   Sifft Eveline   Taylor Ninon   Kenner Lukas   Greil Richard   Merkel Olaf  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 12, 2012-12 ,pp. : 1149-1163

Informa Healthcare

Access to resources Recommend Favorite

New treatment options for opioid dependence

By  

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma

By Duvic Madeleine   Vu Jenny  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-07 ,pp. : 1111-1120

Informa Healthcare

Access to resources Recommend Favorite